Travere Therapeutics Inc (TVTX) reports robust growth in FILSPARI sales and strategic milestones, despite competitive ...
(Don’t worry — it may feel odd, even uncomfortable, but since Baby A essentially warmed up and stretched out the birth canal, ...
Results published in AAST’s Trauma Surgery & Acute Care Open Journal -- Study compared outcomes of patients treated with Symvess with ...
Straight Arrow News on MSN
What we know about Tylenol and autism, as Texas AG Ken Paxton files suit
Texas Attorney General Ken Paxton, R, sued the makers of Tylenol this week, stating that the companies ignored and silenced ...
Generated $459 million in 3Q 2025 revenues, including $178 million in U.S. net product salesReceived 152 new patient start forms for EMPAVELI® ...
36mon MSN
COVID-19 during pregnancy linked to higher risk of neurodevelopmental disorders in children
Children born to mothers who had COVID-19 while pregnant face an elevated risk of developmental disorders by the time they ...
SDLC guides teams to plan, build, test, and deliver software. Discover phases, KPIs, tools, and checklist with our quick ...
Walk into any custodial youth justice facility in the UK—from young offender's institutions to secure training centers and ...
Travere Therapeutics, Inc. today reported its third quarter 2025 financial results and provided a corporate update. "We delivered outstanding commercial performance in the third quarter, reflecting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback